|
RMC-9805 Clinical Trials
4 actively recruiting trials across 4 locations
Chandler, Arizona1 trial
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Ironwood Cancer and Research Centers
Phase 1/2
Gilbert, Arizona1 trial
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Banner MD Anderson Cancer Center
Phase 1/2
Scottsdale, Arizona1 trial
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Mayo Clinic Scottsdale
Phase 1/2
Sacramento, California1 trial
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
University of California, Davis Comprehensive Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.